Physician profile
Peter A Ruff
NPI 1487646790
$168,338.02
in general payments reported to CMS, 2019-2025
32 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $10K · 2021: $22K · 2022: $22K · 2023: $12K · 2024: $64K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $74K · Travel and Lodging: $9,270 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,000 · Food and Beverage: $5,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $74,266.30 |
| Travel and Lodging | $9,270.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,000.00 |
| Food and Beverage | $5,650.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $164,040.30 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $1,408.42 | 2019-2025 | Botox, Lupron Depot |
| Neotract INC. | $1,280.44 | 2019-2020 | |
| Pfizer INC. | $283.07 | 2019-2025 | |
| Astellas Pharma US INC | $209.64 | 2019-2021 | |
| Olympus America INC. | $102.98 | 2024-2025 | Itind System |
| Procept Biorobotics Corporation | $94.63 | 2024 | Aquabeam System |
| Dornier Medtech America, INC | $93.76 | 2019 | |
| Myovant Sciences INC. | $80.39 | 2021 | |
| Becton, Dickinson and Company | $80.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $65.78 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $62.39 | 2022 | |
| Sumitomo Pharma America, INC. | $62.04 | 2023-2024 | Orgovyx, Gemtesa |
| Innovation Technologies INC | $48.90 | 2024 | Irrisept |
| Boston Scientific Corporation | $45.19 | 2022-2024 | Ams 700 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $45.19 | 2021 | |
| Urovant Sciences INC | $32.97 | 2021-2022 | |
| Tela Bio, INC. | $30.81 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endo Pharmaceuticals INC. | $27.72 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $27.34 | 2023 | Pylarify |
| Astrazeneca Pharmaceuticals Lp | $25.08 | 2025 | Lynparza |
| Rochester Medical Corporation | $23.12 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $22.36 | 2019 | |
| Merck Sharp & Dohme LLC | $20.73 | 2021 | |
| Travere Therapeutics, INC. | $20.11 | 2020 | |
| Janssen Biotech, INC. | $19.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.30 | 2023 | |
| Abbott Laboratories | $15.06 | 2023 | Proclaim |
| Ambu INC. | $14.41 | 2021 | |
| Allergan, INC. | $13.98 | 2019 | |
| Urogen Pharma, INC. | $13.13 | 2021 | |
| Antares Pharma, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ruff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.